Informação sobre produto
- 1H-Purine-2,6-dione, 3,7-dihydro-7-(3-((2-hydroxy-3-((2-methyl-1H-indol-4-yl)oxy)propyl)amino)butyl)-1,3-dimethyl-
- 3,7-Dihydro-7-[3-[[2-hydroxy-3-[(2-methyl-1H-indol-4-yl)oxy]propyl]amino]butyl]-1,3-dimethyl-1H-purine-2,6-dione
- 7-(3-((2-Hydroxy-3-((2-methylindol-4-yl)oxy)propyl)amino)butyl)theophylline
- 7-[3-({2-hydroxy-3-[(2-methyl-1H-indol-4-yl)oxy]propyl}amino)butyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
- Brn 1234202
- D-13,312
- Teoprolol [INN]
- Teoprololum
- Teoprololum [INN-Latin]
Teoprolol is a beta-adrenergic antagonist that competes with catecholamines for binding to the beta-adrenergic receptors in the heart. It is used to treat ventricular dysfunction and cardiac arrhythmia and has been shown to be effective against congestive heart failure. Teoprolol is a prodrug, which means it is not active when taken orally; it must be reconstituted before administration. The drug's effects are due to its ability to block the catecholamine receptor, preventing stimulation of the cardiac muscle. This causes an increase in fatty acid oxidation and decrease in lipoprotein levels, resulting in decreased cholesterol levels. Teoprolol also inhibits enzymes that produce fatty alcohols and amides, which can lead to decreased cardiac arrhythmias.
Propriedades químicas
Consulta técnica sobre: 3D-QCA18410 Teoprolol
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.